ADCAMLYX

Welcome to the Brand page for “ADCAMLYX”, which is offered here for Pharmaceuticals; pharmaceutical preparations for use in humans, chemotherapeutics; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology, ophthalmology, gastroenterology, and tissue and organ transplantology;.

Its status is currently believed to be active. Its class is unavailable. “ADCAMLYX” is believed to be currently owned by “Seattle Genetics, Inc.”

Owner:
SEATTLE GENETICS, INC.
Owner Details
Description:
PHARMACEUTICALS; PHARMACEUTICAL PREPARATIONS FOR USE IN HUMANS, CHEMOTHERAPEUTICS; PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF DISORDERS OF THE NERVOUS SYSTEM, THE IMMUNE SYSTEM, THE CARDIO-VASCULAR SYSTEM, THE METABOLIC SYSTEM, THE RESPIRATORY SYSTEM, THE MUSCULO-SKELETAL SYSTEM, AND THE GENITOURINARY SYSTEM; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER, AUTOIMMUNE DISEASES, AND INFLAMMATORY DISORDERS; PHARMACEUTICAL PREPARATIONS FOR USE IN DERMATOLOGY, ONCOLOGY, HEMATOLOGY, OPHTHALMOLOGY, GASTROENTEROLOGY, AND TISSUE AND ORGAN TRANSPLANTOLOGY;
Categories: PHARMACEUTICALS